Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Aclaris Therapts (ACRS)

Aclaris Therapts (ACRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 99,771
  • Shares Outstanding, K 71,265
  • Annual Sales, $ 31,250 K
  • Annual Income, $ -88,480 K
  • 60-Month Beta 0.27
  • Price/Sales 3.03
  • Price/Cash Flow N/A
  • Price/Book 0.66
Trade ACRS with:

Options Overview Details

View History
  • Implied Volatility 60.56% ( +60.56%)
  • Historical Volatility 66.93%
  • IV Percentile 18%
  • IV Rank 10.05%
  • IV High 494.95% on 10/26/23
  • IV Low 12.02% on 06/21/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 19
  • Volume Avg (30-Day) 54
  • Put/Call OI Ratio 0.10
  • Today's Open Interest 1,171
  • Open Int (30-Day) 1,081

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.19
  • Number of Estimates 6
  • High Estimate -0.12
  • Low Estimate -0.24
  • Prior Year -0.42
  • Growth Rate Est. (year over year) +54.76%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1000 +27.27%
on 07/01/24
1.4300 -2.10%
on 07/17/24
+0.2500 (+21.74%)
since 06/21/24
3-Month
0.9515 +47.14%
on 05/29/24
1.4300 -2.10%
on 07/17/24
+0.1800 (+14.75%)
since 04/23/24
52-Week
0.5902 +137.21%
on 11/13/23
10.7150 -86.93%
on 07/24/23
-9.2200 (-86.82%)
since 07/21/23

Most Recent Stories

More News
Aclaris: Q1 Earnings Snapshot

Aclaris: Q1 Earnings Snapshot

ACRS : 1.4000 (+5.26%)
Biotech Sector Advances in Pancreatic Cancer Research

USA News Group – Known as one of the most deadly forms of cancer, pancreatic cancer still has the highest mortality rate of all major cancers today. However, researchers and the biotech sector are working...

BRX : 24.71 (+0.04%)
ONCY : 1.0200 (unch)
ONC.TO : 1.42 (unch)
NVS : 107.70 (-0.95%)
IBRX : 5.65 (-1.05%)
ACRS : 1.4000 (+5.26%)
NUVB : 3.28 (+4.79%)
Biotech’s Role in Addressing the Pancreatic Cancer Emergency

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:NVX),(NASDAQ:IBRX),(NASDAQ:ACRS),(NYSE:NUVB) EQNX::TICKER_END

NVX : 1.7820 (+0.11%)
ONCY : 1.0200 (unch)
ONC.TO : 1.42 (unch)
NVS : 107.70 (-0.95%)
IBRX : 5.65 (-1.05%)
ACRS : 1.4000 (+5.26%)
NUVB : 3.28 (+4.79%)
Aclaris: Q4 Earnings Snapshot

Aclaris: Q4 Earnings Snapshot

ACRS : 1.4000 (+5.26%)
Aclaris: Q3 Earnings Snapshot

Aclaris: Q3 Earnings Snapshot

ACRS : 1.4000 (+5.26%)
Why Aclaris Therapeutics Stock Soared Nearly 6% on Thursday

A bull on the company became more positive on its prospects.

SF : 82.36 (+0.43%)
ACRS : 1.4000 (+5.26%)
Aclaris: Q2 Earnings Snapshot

Aclaris: Q2 Earnings Snapshot

ACRS : 1.4000 (+5.26%)
2 Low-Priced Stocks That Could Make You Richer

These two low-priced healthcare stocks could skyrocket within the next 12 months.

GILD : 71.17 (-1.71%)
INCY : 65.80 (+0.94%)
VKTX : 51.54 (-0.33%)
AXSM : 85.66 (-0.45%)
MRK : 124.38 (-1.04%)
BMY : 42.98 (+0.73%)
AGEN : 6.91 (+0.88%)
ACRS : 1.4000 (+5.26%)
Why Aclaris Therapeutics Topped the Market on Tuesday

Investors were cheered by the latest laboratory news from the company.

ACRS : 1.4000 (+5.26%)
Aclaris: Q1 Earnings Snapshot

Aclaris: Q1 Earnings Snapshot

ACRS : 1.4000 (+5.26%)

Business Summary

Aclaris Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing drugs to met needs in dermatology. Its drug candidate consists of A-101, a high-concentration hydrogen peroxide topical solution which is being developed as a prescription...

See More

Key Turning Points

3rd Resistance Point 1.4667
2nd Resistance Point 1.4333
1st Resistance Point 1.4167
Last Price 1.4000
1st Support Level 1.3667
2nd Support Level 1.3333
3rd Support Level 1.3167

See More

52-Week High 10.7150
Fibonacci 61.8% 6.8473
Fibonacci 50% 5.6526
Fibonacci 38.2% 4.4579
Last Price 1.4000
52-Week Low 0.5902

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar